FDA Inspection 1122366 — Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit
The FDA completed an inspection of Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit on March 12, 2020 in Amman. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 12, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Amman (Jordan)
Additional Details
Clinical BA/BE